1. Home
  2. ARTV vs SFWL Comparison

ARTV vs SFWL Comparison

Compare ARTV & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • SFWL
  • Stock Information
  • Founded
  • ARTV 2019
  • SFWL 2001
  • Country
  • ARTV United States
  • SFWL China
  • Employees
  • ARTV N/A
  • SFWL N/A
  • Industry
  • ARTV
  • SFWL Trucking Freight/Courier Services
  • Sector
  • ARTV
  • SFWL Industrials
  • Exchange
  • ARTV NYSE
  • SFWL Nasdaq
  • Market Cap
  • ARTV 61.9M
  • SFWL 74.2M
  • IPO Year
  • ARTV 2024
  • SFWL 2023
  • Fundamental
  • Price
  • ARTV $1.93
  • SFWL $1.02
  • Analyst Decision
  • ARTV Strong Buy
  • SFWL
  • Analyst Count
  • ARTV 7
  • SFWL 0
  • Target Price
  • ARTV $19.17
  • SFWL N/A
  • AVG Volume (30 Days)
  • ARTV 147.5K
  • SFWL 10.3K
  • Earning Date
  • ARTV 05-08-2025
  • SFWL 06-10-2025
  • Dividend Yield
  • ARTV N/A
  • SFWL N/A
  • EPS Growth
  • ARTV N/A
  • SFWL 4.79
  • EPS
  • ARTV N/A
  • SFWL 0.13
  • Revenue
  • ARTV N/A
  • SFWL $504,158,000.00
  • Revenue This Year
  • ARTV N/A
  • SFWL N/A
  • Revenue Next Year
  • ARTV N/A
  • SFWL N/A
  • P/E Ratio
  • ARTV N/A
  • SFWL $7.72
  • Revenue Growth
  • ARTV N/A
  • SFWL 24.75
  • 52 Week Low
  • ARTV $1.78
  • SFWL $0.81
  • 52 Week High
  • ARTV $17.31
  • SFWL $2.15
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • SFWL 54.75
  • Support Level
  • ARTV N/A
  • SFWL $0.94
  • Resistance Level
  • ARTV N/A
  • SFWL $1.02
  • Average True Range (ATR)
  • ARTV 0.00
  • SFWL 0.05
  • MACD
  • ARTV 0.00
  • SFWL -0.00
  • Stochastic Oscillator
  • ARTV 0.00
  • SFWL 68.67

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.

Share on Social Networks: